Cargando…

Chronic hepatitis B infection and non-hepatocellular cancers: A hospital registry-based, case-control study

BACKGROUND: Prior epidemiological evidences suggest that hepatitis B virus (HBV) infection is linked to cancers other than hepatocellular carcinoma. This prospective hospital registry-based case-control study aimed to investigate the sero-epidemiological association between chronic HBV infection and...

Descripción completa

Detalles Bibliográficos
Autores principales:	An, Jihyun, Kim, Jong Woo, Shim, Ju Hyun, Han, Seungbong, Yu, Chang Sik, Choe, Jaewon, Lee, Danbi, Kim, Kang Mo, Lim, Young-Suk, Chung, Young-Hwa, Lee, Yung Sang, Suh, Dong Jin, Kim, Jin Hyoung, Lee, Han Chu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854295/ https://www.ncbi.nlm.nih.gov/pubmed/29543815 http://dx.doi.org/10.1371/journal.pone.0193232

Ejemplares similares

Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion
por: Lee, Danbi, et al.
Publicado: (2018)

A simple and clinically applicable model to predict liver-related morbidity after hepatic resection for hepatocellular carcinoma
por: Choi, Jonggi, et al.
Publicado: (2020)

Clinical features and outcomes of patients with hepatocellular carcinoma complicated with bile duct invasion
por: An, Jihyun, et al.
Publicado: (2017)

Evaluation of transarterial chemoembolization refractoriness in patients with hepatocellular carcinoma
por: Choi, Jonggi, et al.
Publicado: (2020)

The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection
por: Na, Seong Kyun, et al.
Publicado: (2018)

Could HBx Protein Expression Affect Signal Pathway Inhibition by Gefitinib or Selumetinib, a MEK Inhibitor, in Hepatocellular Carcinoma Cell Lines?
por: Park, Yoon Kyung, et al.
Publicado: (2011)

Stereotactic body radiation therapy for small (≤5 cm) hepatocellular carcinoma not amenable to curative treatment: Results of a single-arm, phase II clinical trial
por: Yoon, Sang Min, et al.
Publicado: (2020)

Applicability of the BCLC staging system to patients with hepatocellular carcinoma in Korea: analysis at a single center with a liver transplant center
por: Kim, Sung Eun, et al.
Publicado: (2011)

Identification of hepatic steatosis in living liver donors by machine learning models
por: Lim, Jihye, et al.
Publicado: (2022)

Role of 15-hydroxyprostaglandin dehydrogenase down-regulation on the prognosis of hepatocellular carcinoma
por: Yang, Jee Eun, et al.
Publicado: (2014)

Alpha-fetoprotein normalization as a prognostic surrogate in small hepatocellular carcinoma after stereotactic body radiotherapy: a propensity score matching analysis
por: Jung, Jinhong, et al.
Publicado: (2015)

Role of transarterial chemoembolization in relation with sorafenib for patients with advanced hepatocellular carcinoma
por: Ha, Yeonjung, et al.
Publicado: (2016)

Telbivudine versus entecavir in patients with undetectable hepatitis B virus DNA: a randomized trial
por: An, Jihyun, et al.
Publicado: (2017)

Stereotactic body radiation therapy for elderly patients with small hepatocellular carcinoma: a retrospective observational study
por: Jang, Jeong Yun, et al.
Publicado: (2022)

Development of machine learning-based clinical decision support system for hepatocellular carcinoma
por: Choi, Gwang Hyeon, et al.
Publicado: (2020)

No association between the IL28B SNP and response to peginterferon plus ribavirin combination treatment in Korean chronic hepatitis C patients
por: Heo, Nae-Yun, et al.
Publicado: (2014)

Subclassification of advanced-stage hepatocellular carcinoma with macrovascular invasion: combined transarterial chemoembolization and radiotherapy as an alternative first-line treatment
por: Jin, Sujin, et al.
Publicado: (2023)

The Korean Hepatitis C Virus Care Cascade in a Tertiary Institution: Current Status and Changes in Testing, Link to Care, and Treatment
por: Choi, Jonggi, et al.
Publicado: (2022)

Loco-regional therapies competing with radiofrequency ablation in potential indications for hepatocellular carcinoma: a network meta-analysis
por: Kim, Ha Il, et al.
Publicado: (2023)

The role of muscle depletion and visceral adiposity in HCC patients aged 65 and over undergoing TACE
por: Lim, Jihye, et al.
Publicado: (2021)

Ranking of transarterial and targeted therapies for advanced hepatocellular carcinoma in the era of immuno‐oncology: A network meta‐analysis of randomized sorafenib‐controlled trials
por: An, Jihyun, et al.
Publicado: (2022)

Safety of direct oral anticoagulants compared to warfarin in cirrhotic patients with atrial fibrillation
por: Yoo, Seo Yeon, et al.
Publicado: (2022)

Regorafenib Versus Nivolumab After Sorafenib Failure: Real‐World Data in Patients With Hepatocellular Carcinoma
por: Choi, Won‐Mook, et al.
Publicado: (2020)

Propensity Score Matching Analysis of Changes in Alpha-Fetoprotein Levels after Combined Radiotherapy and Transarterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
por: Jeong, Yuri, et al.
Publicado: (2015)

Stereotactic Body Radiation Therapy as an Alternative Treatment for Small Hepatocellular Carcinoma
por: Yoon, Sang Min, et al.
Publicado: (2013)

Osler-Weber-Rendu disease presenting with hepatocellular carcinoma: radiologic and genetic findings
por: Lee, Joo Ho, et al.
Publicado: (2011)

Stereotactic body radiation therapy as a salvage treatment for single viable hepatocellular carcinoma at the site of incomplete transarterial chemoembolization: a retrospective analysis of 302 patients
por: Lee, Sumin, et al.
Publicado: (2022)

Association between statin use and the prognosis of hepatocellular carcinoma after resection: a nationwide cohort study
por: Jeon, Dongsub, et al.
Publicado: (2023)

Effectiveness and Safety of Nivolumab in Child–Pugh B Patients with Hepatocellular Carcinoma: A Real-World Cohort Study
por: Choi, Won-Mook, et al.
Publicado: (2020)

Fibroblast growth factor receptor isotype expression and its association with overall survival in patients with hepatocellular carcinoma
por: Lee, Hyo Jeong, et al.
Publicado: (2015)

Increasing on-treatment hepatocellular carcinoma risk with decreasing baseline viral load in HBeAg-positive chronic hepatitis B
por: Choi, Won-Mook, et al.
Publicado: (2022)

Clinical course of chronic hepatitis B patients who were off-treated after lamivudine treatment: analysis of 138 consecutive patients
por: Jin, Young-Joo, et al.
Publicado: (2012)

Adefovir Dipivoxil Alone or in Combination with Ongoing Lamivudine in Patients with Decompensated Liver Disease and Lamivudine-resistant Hepatitis B Virus
por: Kim, Kang Mo, et al.
Publicado: (2005)

Hepatocellular Carcinoma in Korea: an Analysis of the 2015 Korean Nationwide Cancer Registry
por: Yoon, Jun Sik, et al.
Publicado: (2021)

Hepatocellular Carcinoma in Korea Between 2008 and 2011: an Analysis of Korean Nationwide Cancer Registry
por: Yoon, Jun Sik, et al.
Publicado: (2020)

Variceal bleeding is aggravated by portal venous invasion of hepatocellular carcinoma: a matched nested case-control study
por: Lim, Jihye, et al.
Publicado: (2021)

Hepatocellular Carcinoma in Korea between 2012 and 2014: an Analysis of Data from the Korean Nationwide Cancer Registry
por: Chon, Young Eun, et al.
Publicado: (2020)

Survival Outcomes According to Body Mass Index in Hepatocellular Carcinoma Patient: Analysis of Nationwide Cancer Registry Database
por: Cha, Boram, et al.
Publicado: (2020)

Prospective Multi-Center Korean Registry of Transcatheter Arterial Chemoembolization with Drug-Eluting Embolics for Nodular Hepatocellular Carcinoma: A Two-Year Outcome Analysis
por: Lee, Myungsu, et al.
Publicado: (2021)

Clinicobiochemical prediction of biopsy-proven cases of severe hepatic fibrosis in patients with chronic hepatitis C infection
por: Jin, Young-Joo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3cqnnl6fvtj0v2uag40lo48nru